MASHA MOBBLEY: Open Payments
NPI 1063862605 · MILL CREEK, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,328 in 69 payments from 14 companies in 2025. Trend: 2023 $1,420 · 2024 $1,846 · 2025 $1,328
Food & beverage: $1,228Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $353 |
| Regeneron Healthcare Solutions, Inc. | 11 | $262 |
| ABBVIE INC. | 17 | $240 |
| GENZYME CORPORATION | 3 | $101 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| Organon LLC | 5 | $61 |
| Galderma Laboratories, L.P. | 3 | $60 |
| UCB, Inc. | 3 | $50 |
| Lilly USA, LLC | 1 | $34 |
| Biocon Biologics Inc | 1 | $22 |
Products named: DUPIXENT, TREMFYA, RINVOQ, SKYRIZI, COSENTYX, VTAMA, Bimzelx, NEMLUVIO.
Industry payments across WA — which companies pay providers there.
